QGEN - Qiagen N.V.
NEXT EARNINGS:
May 6, 2026
EPS Est: $0.56
|
Rev Est: $501.4M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$54.33
DETAILS
HIGH:
$59.00
LOW:
$50.00
MEDIAN:
$53.50
CONSENSUS:
$54.33
UPSIDE:
12.02%
Market Cap:
9.99B
Volume:
1,819,320
Avg Volume:
2,104,200
52 Week Range:
37.63-57.82
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
0.68
Last Dividend:
$0.26
Exchange:
NYSE
Country:
NL
Employees:
5,700
IPO Date:
1996-06-28
EPS (TTM):
2.04
P/E Ratio:
23.17
Revenue (TTM):
2.09B
Total Assets:
6.30B
Total Debt:
1.65B
Cash & Equiv:
839.00M
Rev Growth (5Y):
2.2%
EPS Growth (5Y):
44.0%
FCF Growth (5Y):
19.2%
ROCE:
9.1%
Debt/Equity:
0.44
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $0.62 | $0.61 | +1.6% | $540.4M | $501.4M | +7.8% |
| 2025-11-04 | $0.64 | $0.61 | +4.9% | $532.6M | $525.9M | +1.3% |
| 2025-08-05 | $0.60 | $0.60 | 0.0% | $533.5M | $515.8M | +3.4% |
| 2025-05-07 | $0.55 | $0.50 | +9.3% | $483.5M | $468.9M | +3.1% |
| 2025-02-05 | $0.61 | $0.60 | +1.7% | $521.2M | $518.5M | +0.5% |
| 2024-11-06 | $0.57 | $0.54 | +5.6% | $502.6M | $491.7M | +2.2% |
| 2024-07-31 | $0.57 | $0.53 | +7.5% | $496.3M | $491.7M | +0.9% |
| 2024-04-29 | $0.46 | $0.44 | +4.5% | $458.8M | $457.3M | +0.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.09B | 1.98B | 1.97B | 2.14B | 2.25B | 1.87B | 1.53B | 1.50B | 1.42B | 1.34B | 1.28B | 1.34B |
| Net Income | 424.88M | 83.59M | 341.30M | 423.21M | 512.60M | 359.19M | (41.45M) | 190.38M | 40.39M | 80.40M | 130.15M | 116.36M |
| EPS | 2.04 | 0.39 | 1.54 | 1.92 | 2.32 | 0.33 | -0.19 | 0.84 | 0.18 | 0.36 | 0.57 | 0.52 |
| Total Assets | 6.30B | 5.69B | 6.12B | 6.29B | 6.15B | 5.87B | 5.24B | 5.75B | 5.04B | 4.31B | 4.19B | 4.45B |
| Total Debt | 1.65B | 1.42B | 1.53B | 1.88B | 1.96B | 1.95B | 1.73B | 2.17B | 1.77B | 1.08B | 1.06B | 1.28B |
| Cash & Equivalents | 839.00M | 663.55M | 668.08M | 730.67M | 880.52M | 597.98M | 623.65M | 1.18B | 679.62M | 439.18M | 292.51M | 396.20M |
| Operating Cash Flow | 654.33M | 673.55M | 459.45M | 715.26M | 639.00M | 492.27M | 330.84M | 359.50M | 286.78M | 341.60M | 317.50M | 287.96M |
| Free Cash Flow | 453.28M | 506.38M | 296.65M | 565.93M | 432.47M | 188.03M | 55.96M | 208.73M | 162.37M | 247.68M | 200.02M | 190.96M |
| FCF per Share | 2.18 | 2.34 | 1.36 | 2.56 | 1.96 | 0.85 | 0.25 | 0.93 | 0.71 | 1.10 | 0.89 | 0.85 |
| Book Value | 3.78B | 3.57B | 3.81B | 3.47B | 3.10B | 2.80B | 2.54B | 2.63B | 2.54B | 2.61B | 2.56B | 2.58B |
| Cash & ST Investments | 1.10B | 1.15B | 1.06B | 1.42B | 1.07B | 715.23M | 753.23M | 1.42B | 1.04B | 532.18M | 423.33M | 580.24M |
| ROC Equity | 0.11 | 0.02 | 0.09 | 0.12 | 0.17 | 0.13 | -0.02 | 0.07 | 0.02 | 0.03 | 0.05 | 0.05 |